Home › Colorectal Cancer › Nebraska › Lincoln
Colorectal Cancer clinical trials in Lincoln, NE
4 studies for Colorectal Cancer are looking for participants at sites in and around Lincoln (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Cancer Partners of Nebraska, Lincoln
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RecruitingPhase 3
- Clinical Study Site, Lincoln
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RecruitingPhase 2
- NHO Revive Research Institute, Lincoln
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Recruiting
- Bryan Medical Center, Lincoln
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY77 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA38 studies
- Seattle, WA34 studies
Other studies in Lincoln
- Non-Small Cell Lung Cancer16 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Coronary Artery Disease5 studies
- Breast Cancer4 studies
- Obesity4 studies
- Schizophrenia4 studies
- Multiple Myeloma3 studies
- Melanoma3 studies
- Amyotrophic Lateral Sclerosis3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.